Kaya Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet
TCPL Packaging Limited has informed the Exchange about Schedule of meet
Black Box Limited has informed the Exchange about Schedule of meet
DCB Bank Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Ugro Capital Limited has informed the Exchange about Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018
Balrampur Chini Mills Limited has informed the Exchange about Schedule of meet
Uttam Sugar Mills Limited has informed the Exchange about Redemption of Preference shares
Cinevista Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2022, titled Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single‐Dose Pre‐Filled Syringe.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.